Linda C Laux

  • 1142 Citations
20072019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My clinical and research focus is epilepsy syndromes, genetics of epilepsy syndromes, and Dravet syndrome.

Certifications and Licenses

Clinical Neurophysiology
Child Neurology

Training Experience

1993Residency, University of Arizona Health Science Center
1997Fellowship, Saint Joseph's Hospital, Phoenix
2001Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, Saint Louis University

… → 1990

Research interests

  • EEG
  • Epigenetics
  • Epilepsy
  • Pediatric Neurology

Fingerprint Dive into the research topics where Linda C Laux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Myoclonic Epilepsy Medicine & Life Sciences
Seizures Medicine & Life Sciences
Cannabidiol Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Ketogenic Diet Medicine & Life Sciences
Brain Diseases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Anticonvulsants Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2013 2014

Dravet Syndrome Database

Laux, L. C.

Dravet Syndrome Foundation

9/1/139/30/14

Project: Research project

Research Output 2007 2019

  • 1142 Citations
  • 24 Article
  • 1 Comment/debate
  • 1 Letter
5 Citations (Scopus)

Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial

Devinsky, O., Nabbout, R., Miller, I., Laux, L. C., Zolnowska, M., Wright, S. & Roberts, C., Feb 1 2019, In : Epilepsia. 60, 2, p. 294-302 9 p.

Research output: Contribution to journalArticle

Cannabidiol
Myoclonic Epilepsy
Seizures
Therapeutics
Caregivers
1 Citation (Scopus)

Long-term safety and efficacy of cannabidiol in children and adults with treatmentresistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results

Laux, L. C., Bebin, E. M., Checketts, D., Chez, M., Flamini, R., Marsh, E. D., Miller, I., Nichol, K., Park, Y., Segal, E., Seltzer, L., Szaflarski, J. P., Thiele, E. A. & Weinstock, A., Aug 1 2019, In : Epilepsy Research. 154, p. 13-20 8 p.

Research output: Contribution to journalArticle

Open Access
Cannabidiol
Myoclonic Epilepsy
Seizures
Safety
Anticonvulsants

Seizure burden in severe early-life epilepsy: Perspectives from parents

Berg, A. T., Kaiser, K., Dixon-Salazar, T., Elliot, A., McNamara, N., Meskis, M. A., Golbeck, E., Tatachar, P., Laux, L. C., Raia, C., Stanley, J., Luna, A. & Rozek, C., Jun 1 2019, In : Epilepsia Open. 4, 2, p. 293-301 9 p.

Research output: Contribution to journalArticle

Open Access
Epilepsy
Seizures
Parents
Education
Caregivers

The ketogenic diet in children 3 years of age or younger: a 10-year single-center experience

Kim, S. H., Shaw, A., Blackford, R., Lowman, W., Laux, L. C., Millichap, J. J. & Nordli, D. R., Dec 1 2019, In : Scientific reports. 9, 1, 8736.

Research output: Contribution to journalArticle

Open Access
Ketogenic Diet
Seizures
Medical Records
115 Citations (Scopus)

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

GWPCARE4 Study Group, Jan 1 2018, In : The Lancet. 391, 10125, p. 1085-1096 12 p.

Research output: Contribution to journalArticle

Cannabidiol
Seizures
Placebos
Therapeutics
Lennox Gastaut Syndrome